Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
D000547:Amantadine / Q000494:pharmacology*; D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004155:Diphenhydramine / Q000494:pharmacology; D004357:Drug Synergism; D007099:Imipramine / Q000494:pharmacology; D051379:Mice; D009966:Orphenadrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010293:Pargyline; D014282:Trihexyphenidyl / Q000494:pharmacology
D000978:Antiparkinson Agents; D010276:Parasympatholytics; D000639:Amitriptyline; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D001285:Atropine; D004155:Diphenhydramine; D010293:Pargyline; D009966:Orphenadrine; D000547:Amantadine; D007099:Imipramine